View in EDS

Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.

Saved in:
Bibliographic Details
Title: Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
Authors: Kim, Ju-Hwa1, Choi, Ae-Ran1, Kim, Yong Kee2, Yoon, Sungpil1 yoons@ncc.re.kr
Source: Biochemical & Biophysical Research Communications. Nov2013, Vol. 441 Issue 3, p655-660. 6p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first